Ixensor Co

Ixensor Co Capital Intensity

The Capital Intensity Ratio of Ixensor Co (6734.TWO) as of Nov 5, 2026 is 256.59 %. In the previous year, Capital Intensity Ratio was 383.46 % — a change of -33.09% (lower).

Capital Intensity

256.59 %

YoY

-33.09%

Last updated:

Capital Intensity Ratio of Ixensor Co is 2025 256.59 % . Capital Intensity Ratio of Ixensor Co was 2024 383.46 % . It decreases by -33.09% lower compared to the previous year.

The Ixensor Co Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2018
2,254.23 TWD
Jan 1, 2019
597.20 TWD
Jan 1, 2020
612.00 TWD
Jan 1, 2021
296.76 TWD
Jan 1, 2022
99.51 TWD
Jan 1, 2023
461.38 TWD
Jan 1, 2024
383.46 TWD
Jan 1, 2025
256.59 TWD
The Ixensor Co Capital Intensity history
YEARCapital IntensityYoY
256.59 %-33.09%
383.46 %-16.89%
461.38 %+363.65%
99.51 %-66.47%
296.76 %-51.51%
612.00 %+2.48%
597.20 %-73.51%
2,254.23 %+103.89%
1,105.63 %-98.96%
106,086.45 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ixensor Co Stock analysis

What does Ixensor Co do? iXensor Co., Ltd. generates revenue through its PixoTest Blood Glucose Monitoring System and ovulation detection system, targeting individuals managing diabetes and reproductive health. The company's technology platform measures biochemical parameters including blood sugar, luteinizing hormone, and cholesterol, providing data for diabetes management services. Its integrated medical device solutions serve customers seeking self-monitoring tools for chronic conditions and fertility tracking. The firm's products are designed for direct consumer use, with the PixoTest system offering blood glucose monitoring and the ovulation detection system supporting female hormone cycle management. These solutions leverage the company's platform to deliver personalized health insights without requiring third-party partnerships. The target segments include patients with diabetes and individuals tracking fertility cycles through biochemical monitoring. Ixensor Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ixensor Co stock

Capital Intensity Ratio of Ixensor Co is 256.59 % in 2025.

Capital Intensity Ratio of Ixensor Co changed from 383.46 % to 256.59 %, representing a -33.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Ixensor Co since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Ixensor Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Ixensor Co

All Key Metrics — Ixensor Co